Removal of Thrombus from Aortocoronary Bypass Grafts and Coronary Arteries Using the 6Fr Hydrolyser

<b>Percutaneous Coronary Arterial Thrombectomy for Acute Myocardial Infarction Reduces No-Reflow Phenomenon and Protects Against Left Ventricular Remodeling Related to the Proximal Left Anterior Descending and Right Coronary Artery</b>

“…Our results were similar to those of previous reports. Various devices, such as the AngioJet (Possis Medical, Inc., Minneapolis, Minnesota), 23) Hydrolyser (Cordis, Inc., Warren, New Jersey), 24) X-sizer catheter (ev3, Plymouth, Minnesota), [25][26][27] and ultrasound system (Advanced Cardiovascular Systems, Santa Clara, California), 28) Rescue 16) and TVAC system, 17) have been clinically applied in attempts to prevent the no-reflow phenomenon during PCI by removing or dissolving the thrombus in the coronary artery. However, there are no studies that have examined the effects of thrombectomy both for no-reflow phenomenon in the acute phase and LV remodeling in the follow-up phase without distal protection, and there are also no studies that have determined whether the acute and chronic effects of thrombectomy are different between the proximal and distal LAD, RCA and LCX.…”

Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis.

“…The other two devices remove thrombi by the venturi effect from backwardly directed fluid jets. [20][21][22] The Angiojet is the more effective device as it employs several high velocity jets, while the Hydrolyser uses a single fluid channel. Compared with the X-SIZER, the Angiojet is a more complex system, requiring a separate power console to generate some 26 atmospheres of pressure in the fluid jets.…”

Rescue Percutaneous Thrombectomy System Provides Better Angiographic Coronary Flow and Does Not Increase the In-Hospital Cost in Patients With Acute Myocardial Infarction

“…[18][19][20][21] The AngioJet (Possis Medical, Inc, Minneapolis, MN, USA) is a rheolytic thrombectomy device that uses high-velocity water jets to produce a Venturi effect. Nakagawa et al reported the results of 31 patients with acute and recent myocardial infarction treated with the Angiojet; 19 procedural success was achieved in 29 patients (94%) and subsequent stenting was attempted successfully in 12 patients (40%) without thrombotic complications.…”